Shattuck Labs (STTK) Non-Current Assets (2019 - 2026)
Shattuck Labs (STTK) reported Non-Current Assets of $8.4 million for Q1 2026, down 22.26% year-over-year from $10.8 million in Q1 2025, and down 2.14% quarter-over-quarter from $8.6 million in Q4 2025.
Shattuck Labs (STTK) Non-Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Non-Current Assets data on file, last reported at $8.4 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $8.4 million, down 22.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.2 million (down 27.21% YoY), and the FY2025 annual result was $8.6 million, down 27.74% from the prior year.
- Non-Current Assets slipped to $8.4 million in Q1 2026 per STTK's latest filing, from $8.6 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $21.9 million in Q2 2022 and troughed at $8.4 million in Q1 2026.
- A 5-year average of $14.9 million and a median of $15.3 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 177.44% in 2022, then sank 31.67% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $20.7 million in 2022, then fell by 21.2% to $16.3 million in 2023, then slipped by 27.59% to $11.8 million in 2024, then declined by 27.74% to $8.6 million in 2025, then declined by 2.14% to $8.4 million in 2026.
- Business Quant data shows STTK's Non-Current Assets at $8.4 million in Q1 2026, $8.6 million in Q4 2025, and $9.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 9.61 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 10.76 Mn |
| Dec 31, 2024 | 11.83 Mn |
| Sep 30, 2024 | 12.98 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 15.26 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 17.47 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 19.84 Mn |
| Dec 31, 2022 | 20.74 Mn |
| Sep 30, 2022 | 21.43 Mn |
| Jun 30, 2022 | 21.92 Mn |
| Mar 31, 2022 | 15.50 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 8.92 Mn |
| Jun 30, 2021 | 7.90 Mn |